Τρίτη 13 Νοεμβρίου 2018

the Efficacy and Safety of Sugammadex in Children 0-2 Years Old

Conditions:   Anesthesia;   Pediatric Cancer;   Pediatric Tumor;   Pediatric Hepatoblastoma;   Beta-Thalassemia;   Hepatic Metastases Intervention:   Drug: Sugammadex Sponsor:   Federal Research Institute of Pediatric Hematology, Oncology and Immunology Not yet recruiting (Source: ClinicalTrials.gov)

MedWorm Message: If you are looking to buy something in the January Sales please visit TheJanuarySales.com for a directory of all the best sales in the UK. Any income gained via affiliate links keeps MedWorm running.



from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Dn0v2G

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.